Machine Learning

By Jeremy KahnFebruary 16, 2022

By Jeremy KahnFebruary 11, 2022

By Jeremy KahnJanuary 26, 2022

NewslettersWhat a Bristol-Myers project to monitor off-label prescribing says about future uses of A.I.
By Jeremy Kahn and Jonathan VanianJanuary 25, 2022

HealthBioNTech and London A.I. firm create ‘early warning system’ to spot dangerous new COVID-19 variants before they spread
By Jeremy KahnJanuary 12, 2022

By Jeremy KahnJanuary 11, 2022

HealthSanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
By Jeremy KahnJanuary 7, 2022
Most Popular










